Vivus (VVUS +1.3%) moves up today after quietly disclosing in an 8-K with the SEC disclosing...
Vivus (VVUS +1.3%) moves up today after quietly disclosing in an 8-K with the SEC disclosing that its weight-loss drug Qsymia was available in the U.S. market. The announcement was also made on its website, Qsymia.com. Peer competitor Arena Pharmaceuticals (ARNA +1%) also gets a lift on the news, in spite of the fact that its weight-loss drug, Belviq, won't be available until 2013.
From other sites
at Zacks.com (Wed, 10:59AM)
at Zacks.com (Feb 25, 2015)
at Benzinga.com (Feb 24, 2015)
at Benzinga.com (Jan 14, 2015)
at Benzinga.com (Jan 13, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs